History of Invokana
Nationwide Representation from a Knowledgeable Drug Injury Attorney Team
Invokana has made headlines in recent years, not for its miraculous properties but instead for its severe, potentially life-threatening side effects. As lawsuits begin to pour in from injured patients, it’s important to understand the history of the drug and whether you might be eligible to pursue compensation as well. At Arnold & Itkin, we are passionate about helping our clients hold negligent drug manufacturers responsible for the suffering that has been endured. This level of recovery is a testament to the hard work and excellence that we're committed to.
Learn more about Invokana and your legal options by calling Arnold & Itkin at (888) 493-1629! Our nationally-recognized drug injury lawyers can provide you with a free case evaluation.
Initially developed by Mitsubishi Tanabe Pharma in 2012, Invokana is manufactured and marketed by Janssen Pharmaceuticals, which is a division of Johnson & Johnson. Invokana was approved in March of 2013 for the treatment of Type II Diabetes and was the first SGLT2 inhibitor that was approved in the U.S. by the FDA. Since its approval, the FDA has issued several warnings about the side effects of Invokana.
An overview of Invokana developments:
- March 2013: The FDA approves Invokana & the drug makes its debut in the market.
- March 2013: A New York Times article mentions that the FDA ordered post-marketing clinical trials.
- December 2013: Invokana is marketed for weight loss, though not approved by the FDA for that purpose.
- May 2015: The FDA issues a safety warning about ketoacidosis complications.
- September 2015: The FDA requests an update of SGLT2 inhibitor warning labels to include fractures.
- September 2015: Canada sees its first Invokana lawsuit. The U.S. begins to see lawsuits as well.
- December 2015: The FDA revises SGLT2 inhibitor labels to warn about ketoacidosis and risks of UTI.
- January 2016: A report is published by the ISMP that announced 5,484 adverse events were linked to Invokana.
- May 2016: The FDA finds increased risk of leg and foot amputations linked to Invokana.
- June 2016: The FDA strengthens its kidney warnings for Invokana.
Currently, Arnold & Itkin is accepting clients who have experienced serious side effects due to Invokana. We have gone up against Johnson & Johnson with great success and are determined to hold their child-company, Janssen Pharmaceuticals, responsible for their negligence as well. Our award-winning firm, led by skilled and experienced drug injury attorneys Kurt Arnold and Jason Itkin, can represent clients across the nation.
Let us guide you through this difficult time and help you fight for the compensation you deserve. Contact Arnold & Itkin today at (888) 493-1629 for more information about your case.